Crackdown on Illegal Sale of Mephentermine Sulphate Injections in Warangal Gyms

Warangal: In a decisive move against the illegal sale and abuse of prescription drugs in the fitness community, the Drugs Control Administration (DCA) of Telangana has seized stocks of Mephentermine Sulphate Injections from an unlicensed premises in Charbouli, Warangal. The operation, conducted on June 9th, was based on intelligence provided by the Commissioner’s Task Force, Warangal Police.

Officials from the DCA Warangal Zone raided the residence of Mohammed Abdul Sohaib (H. No. 10-9-175/1, Charbouli, Warangal), where they discovered 38 vials of TERMIN Injections (Mephentermine Sulphate Injections IP 30 mg/ml) illegally stocked and sold to gym-goers. These injections, intended for medical use under strict supervision, were being supplied for abuse in bodybuilding circles to enhance endurance and physical performance.

Mephentermine Sulphate Injection is a cardiac stimulant primarily prescribed to treat low blood pressure (hypotension) during surgical procedures. Its misuse, especially without medical oversight, can lead to severe cardiovascular complications and, in extreme cases, death. The DCA emphasized that only qualified doctors should determine the appropriate dosage and duration for this medication.

The DCA warned that the abuse of Mephentermine Sulphate Injections poses significant health risks, including cardiovascular disorders. The illegal stocking and sale of such prescription drugs to gym-goers is a violation of the Drugs and Cosmetics Act, carrying penalties of up to five years imprisonment for those involved.

The raid was executed by Sri P. Shravan Kumar, Drugs Inspector, Warangal, and Sri J. Kiran Kumar, Drugs Inspector, Hanamkonda, under the supervision of Dr. G. Rajyalakshmi, Assistant Director, Warangal.

The Drugs Control Administration urges the public to report any illegal activities related to medicines, including suspected manufacturing or distribution of narcotic drugs and psychotropic substances, in residential, commercial, or industrial areas. Complaints can be made via the DCA Telangana Toll-Free Number: 1800-599-6969 (operational from 10:30 am to 5:00 pm on all working days).

Related Posts

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

NEW DELHI: In a major victory for India’s national security and anti-narcotics apparatus, the Central Bureau of Narcotics (CBN), operating under the Department of Revenue, Ministry of Finance, has dismantled…

National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

NEW DELHI: A worsening maternal health crisis has triggered national panic across India’s public healthcare network following a sudden cluster of severe post-operative complications among C-section patients in Telangana. Coming…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

Chemists demand fair competition in pharma market amid online sales concerns

Chemists demand fair competition in pharma market amid online sales concerns

DCA busts unlicensed shop, seizes meds worth Rs 18000

DCA busts unlicensed shop, seizes meds worth Rs 18000

Health ministry concludes national review meeting on disease surveillance and public health programmes

Health ministry concludes national review meeting on disease surveillance and public health programmes